PhenoSeek AML
A Champions Clinical Flow Cytometry Panel Sheet
The road to an effective treatment for AML patients has been challenging due to the heterogeneity of the disease.
As experts in hematological malignancies, Champions Oncology has developed and optimized the PhenoSeek AML Flow Cytometry Panel in order to interrogate multiple AML populations as well as other immune cell subsets within each clinical sample.
This 18-color panel includes comprehensive immunophenotyping markers for immune cell populations as well as leukemic cell markers detecting AML subset populations.
This panel has been optimized in whole blood from K2 EDTA tubes on the BD Symphony instrument for off-the-shelf use in clinical trial studies.
Download the Panel Sheet